These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 8632606

  • 21. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G, Studnicka-Benke A, Witzmann G, Höfler E, Smolen J.
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [Abstract] [Full Text] [Related]

  • 22. [Role of the TNF system in the pathomechanism of bronchial asthma].
    Halász A, Cserháti E, Cseh K.
    Orv Hetil; 2002 Mar 17; 143(11):553-7. PubMed ID: 12583324
    [Abstract] [Full Text] [Related]

  • 23. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
    Frishman JI, Edwards CK, Sonnenberg MG, Kohno T, Cohen AM, Dinarello CA.
    J Infect Dis; 2000 Dec 17; 182(6):1722-30. PubMed ID: 11069245
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V, Spreafico A, Floriani I, Colombo B, Ludovini V, Pistola L, Bellezza G, Viganò MG, Villa E, Corti A.
    Cancer; 2007 Aug 15; 110(4):845-53. PubMed ID: 17599769
    [Abstract] [Full Text] [Related]

  • 25. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
    Al-Qahtani A, Muttukrishna S, Appasamy M, Johns J, Cranfield M, Visser JA, Themmen AP, Groome NP.
    Clin Endocrinol (Oxf); 2005 Sep 15; 63(3):267-73. PubMed ID: 16117813
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P, Tiberio M, Sivieri S, Facchinetti A, Biasi G, Gallo P.
    Eur Cytokine Netw; 2000 Mar 15; 11(1):81-6. PubMed ID: 10705303
    [Abstract] [Full Text] [Related]

  • 27. Release of tumor necrosis factor alpha and its soluble receptor p55 in clinical septic syndrome.
    Modzelewski B.
    Arch Immunol Ther Exp (Warsz); 1997 Mar 15; 45(2-3):213-9. PubMed ID: 9597089
    [Abstract] [Full Text] [Related]

  • 28. High concentrations of the soluble p55 tumour necrosis factor receptor in human seminal plasma.
    Liabakk NB, Lien E, Sundan A, Sunde A, Austgulen R, Espevik T.
    Hum Reprod; 1993 Nov 15; 8(11):1837-42. PubMed ID: 8288747
    [Abstract] [Full Text] [Related]

  • 29. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
    Kacprzyk F.
    Pol Merkur Lekarski; 2003 Oct 15; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
    [Abstract] [Full Text] [Related]

  • 30. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
    Zhou J, Zhao Q, Yao H.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar 15; 23(3):158-60. PubMed ID: 11778489
    [Abstract] [Full Text] [Related]

  • 31. A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma.
    Brenne AT, Romstad LH, Gimsing P, Juliusson G, Turesson I, Romundstad P, Borset M, Sundan A, Waage A.
    Haematologica; 2004 May 15; 89(5):552-6. PubMed ID: 15136218
    [Abstract] [Full Text] [Related]

  • 32. Detection of soluble tumor necrosis factor-p55 levels in the serum and ascitic fluid of patients with hepatocellular carcinoma.
    Gao L, Bai L, Nan QZ, Yang XS, Chen K, Wen HP, Lai ZS, Bo L, Zhang YL, Zhang ZS.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul 15; 22(7):641-3. PubMed ID: 12376300
    [Abstract] [Full Text] [Related]

  • 33. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
    Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM.
    Eur J Immunol; 1994 Nov 15; 24(11):2699-705. PubMed ID: 7957562
    [Abstract] [Full Text] [Related]

  • 34. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
    Joyce DA, Steer JH.
    J Interferon Cytokine Res; 1995 Nov 15; 15(11):947-54. PubMed ID: 8590306
    [Abstract] [Full Text] [Related]

  • 35. The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's disease.
    Gruss HJ, Dölken G, Brach MA, Mertelsmann R, Herrmann F.
    Leukemia; 1993 Sep 15; 7(9):1339-43. PubMed ID: 8396696
    [Abstract] [Full Text] [Related]

  • 36. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.
    Cope AP, Aderka D, Doherty M, Engelmann H, Gibbons D, Jones AC, Brennan FM, Maini RN, Wallach D, Feldmann M.
    Arthritis Rheum; 1992 Oct 15; 35(10):1160-9. PubMed ID: 1329774
    [Abstract] [Full Text] [Related]

  • 37. Distinct expression levels of cytokines and soluble cytokine receptors in seminal plasma of fertile and infertile men.
    Huleihel M, Lunenfeld E, Levy A, Potashnik G, Glezerman M.
    Fertil Steril; 1996 Jul 15; 66(1):135-9. PubMed ID: 8752625
    [Abstract] [Full Text] [Related]

  • 38. Serum concentrations of TNF-α, sTNF-R p55 and p75 and post-traumatic stress in German soldiers.
    Himmerich H, Willmund GD, Zimmermann P, Wolf JE, Bühler AH, Holdt LM, Teupser D, Kirkby KC, Wesemann U.
    Eur Cytokine Netw; 2015 Sep 15; 26(3):57-60. PubMed ID: 26845055
    [Abstract] [Full Text] [Related]

  • 39. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations.
    Pilz G, Fraunberger P, Appel R, Kreuzer E, Werdan K, Walli A, Seidel D.
    Crit Care Med; 1996 Apr 15; 24(4):596-600. PubMed ID: 8612409
    [Abstract] [Full Text] [Related]

  • 40. Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease.
    Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM.
    J Clin Endocrinol Metab; 1995 Mar 15; 80(3):971-6. PubMed ID: 7883859
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.